1 Min Read
Oct 17 (Reuters) - Astrazeneca Pharma India Ltd:
* Gets marketing approval for Xigduo XR, combination of two anti-diabetic therapies for type 2 diabetes Source text: bit.ly/2yviJMD Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.